Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
December 07 2020 - 4:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced the appointment of Jeanne
Thoma as an independent member of the company’s board of directors.
Ms. Thoma is a seasoned pharmaceutical industry executive with more
than 30 years of experience spanning product development and
commercialization, as well as operations and supply chain
management.
“On behalf of the entire board, I am delighted
to welcome Ms. Thoma with her extensive pharmaceutical industry
expertise to the Avid board of directors,” said Joseph Carleone,
Ph.D., Avid’s chairman of the board.
“Throughout her 30-year career, which spans
tenures with several global leaders in the pharmaceutical and
contract manufacturing space, Ms. Thoma has achieved consistent and
impressive success in establishing and growing innovative
businesses. Her expertise, including her most recent role as
president and CEO of a leading pharmaceuticals ingredients company,
is particularly relevant to Avid’s CDMO business, offering critical
value as we work diligently to continue to grow our client base and
revenue,” said Nicholas Green, president and chief executive
officer of Avid Bioservices. “I join our board in welcoming Ms.
Thoma, as we all look forward to tapping into her broad skillset
and experience to continue to strengthen Avid’s business.”
Ms. Thoma said, “It is an honor to be joining
the accomplished group of professionals on the Avid Board, and the
dynamic executives leading the company. It is an exciting time for
Avid and I am looking forward to supporting their strategic
objectives.”
During her 30-year career, Ms. Thoma has
successfully built innovative, high-performing businesses that
consistently deliver results. She most recently served as president
and chief executive officer of SPI Pharma Inc., a global
pharmaceuticals ingredients company and an innovative solutions
provider of ingredients and drug delivery systems. Prior to SPI,
Ms. Thoma held positions of increasing responsibility at Lonza AG,
a Switzerland-based biotech company, most recently as president and
chief operating officer of the microbial control business sector.
Before joining Lonza, she spent 14 years within the pharma
solutions business at BASF Corporation, during which time she held
various leadership positions in the areas of sales, marketing and
operations. Ms. Thoma is a member of the board of advisors for the
Drug Chemical and Associated Technologies Association (DCAT) and
currently sits on the board of directors of ANI
Pharmaceuticals.
About Avid
Bioservices, Inc.
Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical drug
substances derived from mammalian cell culture. The company
provides a comprehensive range of process development, CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 27 years of
experience producing monoclonal antibodies and recombinant
proteins, Avid's services include CGMP clinical and commercial drug
substance manufacturing, bulk packaging, release and stability
testing and regulatory submissions support. For early-stage
programs the company provides a variety of process development
activities, including upstream and downstream development and
optimization, analytical methods development, testing and
characterization. The scope of our services ranges from
standalone process development projects to full development and
manufacturing programs through
commercialization. www.avidbio.com.
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024